Article
A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.
Human molecular genetics - 15 Feb 2013
Chapman Jade, Rees Elliott, Harold Denise, Ivanov Dobril, Gerrish Amy, Sims Rebecca, Hollingworth Paul, Stretton Alexandra, Holmans Peter, Owen Michael J, O'Donovan Michael C, Williams Julie, Kirov George
Abstract excerpt
We assessed the role of rare copy number variants (CNVs) in Alzheimer's disease (AD) using intensity data from 3260 AD cases and 1290 age-matched controls from the genome-wide association study (GWAS) conducted by the Genetic and Environmental Risk for Alzheimer's disease Consortium (GERAD). We did not observe a significant excess of rare CNVs in cases, although we did identify duplications overlapping APP and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
